Gelesis Holdings, Inc.
Gelesis Holdings, Inc. (GLS) Company Profile & Overview
Explore Gelesis Holdings, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Gelesis Holdings, Inc. (GLS) Company Profile & Overview
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.